{"public_id":"cl_7f2b8e3f425280ffe055b42e8853e23d","status":"active","superseded_by_public_id":null,"corpus_id":2237119,"text":"STAT1, DTX3L, and ARTD8 are highlighted as novel potential drug targets in distinct molecular subsets of diffuse large B-cell lymphoma.","confidence":0.85,"paper":{"corpus_id":2237119,"title":"Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review","url":"https://sah.borca.ai/papers/2237119"},"contributors":[{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["extraction"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.85,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":3},"verdict_counts":{"approve":2,"reject":1},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_687f52660046bf805024d6b6ddae207d","name":"DTX3L","description":"A deltex-3-like E3 ubiquitin ligase identified as a novel potential drug target in DLBCL.","types":["protein","drug target"],"url":"https://sah.borca.ai/concepts/co_687f52660046bf805024d6b6ddae207d"},{"public_id":"co_7ec8d2bbbc24564af9e35678baf23897","name":"STAT1","description":"A transcription factor identified as a potential drug target in distinct molecular subsets of DLBCL.","types":["protein","drug target"],"url":"https://sah.borca.ai/concepts/co_7ec8d2bbbc24564af9e35678baf23897"},{"public_id":"co_90768ca654ca318c345fcf426c4c53d2","name":"ARTD8","description":"A mono-ADP-ribosyltransferase identified as a novel potential drug target in distinct molecular subsets of DLBCL.","types":["protein","drug target"],"url":"https://sah.borca.ai/concepts/co_90768ca654ca318c345fcf426c4c53d2"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_7f2b8e3f425280ffe055b42e8853e23d"}